Showing 13,921 - 13,940 results of 102,312 for search '(( 50 ((mean decrease) OR (teer decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 1.54s Refine Results
  1. 13921

    Glia-targeted 5-HT<sub>2A</sub> receptor expression in adults reopens experience-dependent synaptic glomeruli pruning. by Vanessa Kay Miller (19775496)

    Published 2024
    “…There is a significant decrease in the Or42a OSN innervation volume with glial-targeted <i>Gal80</i><sup><i>ts</i></sup><i>-5-HT</i><sub><i>2A</i></sub><i>R</i> OE at 28°C (<i>n</i> = 20/condition, <i>p</i> = 1.00 × 10<sup>−15</sup>). …”
  2. 13922
  3. 13923

    LdAS-LdPEX5 interactions. by Ines Lakhal-Naouar (125773)

    Published 2012
    “…Bound PTS1 proteins were quantified by an indirect ELISA using anti-V5 or LdIMPDH antisera. (D) LdPEX5 pull-down assay: protein lysates from <i>Ld1S2D</i> were used in a co-immunoprecipitation reaction with Anti-LdPEX5 antibody or preimmune sera (NRS) and the immuno-blot was bound with anti-LdASS antibody. …”
  4. 13924
  5. 13925

    Trends in performance over the five networks. by Alex Greenfield (360670)

    Published 2013
    “…Error distributions of the predictions for the five networks are shown as black boxplots in panels A,B,C. …”
  6. 13926
  7. 13927

    Characteristics of dexmedetomidine use. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. …”
  8. 13928

    Baseline characteristics. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. …”
  9. 13929

    NARS2 homodimerization and RNA level: effect of the p.Val213Phe and p.Asn381Ser mutations. by Mariella Simon (711384)

    Published 2015
    “…In fibroblasts of patient II.1, from LS06 family, the level of mt-tRNA<sup>Asn</sup> is decreased compared to his parents and a control sample. …”
  10. 13930
  11. 13931

    Data that underlies Fig 5 of this paper. by Somya Aggarwal (9299762)

    Published 2024
    “…Murine NoV (MNoV) is a tractable <i>in vivo</i> model for the study of host regulation of NoV. …”
  12. 13932
  13. 13933
  14. 13934

    V2G smart scheme. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  15. 13935
  16. 13936

    T cell survival is regulated by DUSP5. by Raman G. Kutty (3390200)

    Published 2016
    “…<p>A: Legend for Annexin V/ Propidium Iodide flow plots (left) and representative flow plots of WT and <i>Dusp5</i><sup><i>-/-</i></sup> samples (right). …”
  17. 13937

    Source data for Fig 5D. by Isabel Raposo (21615517)

    Published 2025
    “…Here, we combined computational simulations with a multimodal approach encompassing five experiments, and three different variants of classic spatial attention paradigms, to differentiate aperiodic from oscillatory-based sampling. …”
  18. 13938
  19. 13939

    Variants encoding a restricted carboxy-terminal domain of <i>SLC12A2</i> cause hereditary hearing loss in humans by Hideki Mutai (723246)

    Published 2020
    “…Using whole-exome analysis of three families with congenital, severe-to-profound hearing loss, we identified a missense variant of <i>SLC12A2</i> in five affected members of one family showing a dominant inheritance mode, along with <i>de novo</i> splice-site and missense variants of <i>SLC12A2</i> in two sporadic cases, as promising candidates associated with hearing loss. …”
  20. 13940

    VDR regulates TRPV5 expression. by YongMing Chen (5104925)

    Published 2018
    “…<p>(A) RT-PCR and (B) WB were performed to examine the expression of TRPV5 following VDR overexpression or knockdown in caki-1 cells. …”